Real World Evidence
At Sapphire Clinics we are committed to providing high quality care and ensuring our work has the potential to impact the lives of all patients who live with chronic health conditions, where medical cannabis is prescribed.
In addition to using real world data from patients to continuously improve the care we provide, we publish our research globally to help increase the understanding of the effects of medical cannabis.
UK Medical Cannabis Registry
We have set up the UK Medical Cannabis Registry, the largest patient registry to study these medications with approval from the Health Research Authority.
The Registry ensures that medical cannabis prescribing is evaluated in a responsible way, capturing essential data including prescribed formulations, adverse events, and patient-reported health outcomes.
Data is collected from patients with a range of conditions across the UK, who have given consent. Data collection is simple, with the process seamlessly integrated into the Sapphire Clinics Webapp, meaning users can enter their data securely online.
For further enquiries, please contact: [email protected]
Sapphire Access Scheme
Patients at Sapphire Medical Clinics who enrol on the Sapphire Access Scheme can contribute directly to the UK Medical Cannabis Registry. Through this scheme UK medical cannabis patients can:
Publications
Sapphire Clinics is determined to uphold the highest standards in all research activities and publishes findings from the UK Medical Cannabis Registry in peer-reviewed journals.
For more research from the UK Medical Cannabis Registry and wider industry please click here
2023
2022
Clinical Trials
At Sapphire Clinics we understand the importance of generating high level evidence and allowing patients access to clinical trials.
As we are led by several prominent academic clinicians based at institutions, including Imperial College and Kings College, we are actively involved in this process.
We have therefore set up a clinical trials hub through which patients can access studies nationally and through which academia, industry, regulators, and funding bodies can deliver collaborative research projects aimed to generate the data necessary to inform public policy recommendations and support drug licensing.
The Sapphire Clinical Trials hub is ideally suited as a vehicle to recruit patients for clinical trials ranging from early phase 1 to multi-national randomised controlled trials. We welcome partnerships with academia and industry to support generation of robust datasets, and we have the tools and infrastructure in place to deliver regulatory grade evidence using our real world data acquisition platform.
For further information please contact: [email protected]
